Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 09, 2023

SELL
$68.48 - $81.09 $10,272 - $12,163
-150 Reduced 7.73%
1,791 $129 Million
Q1 2022

May 09, 2023

BUY
$61.48 - $73.72 $119,332 - $143,090
1,941 New
1,941 $142 Million
Q3 2017

Jun 01, 2023

SELL
$55.23 - $63.74 $371,863 - $429,161
-6,733 Closed
0 $0
Q2 2017

Jun 01, 2023

SELL
N/A
-1,023 Reduced 13.19%
6,733 $375 Million
Q1 2017

Jun 01, 2023

SELL
N/A
-50 Reduced 0.64%
7,756 $422 Million
Q3 2015

Jun 01, 2023

BUY
N/A
400 Added 5.4%
7,806 $462 Million
Q2 2015

Jun 01, 2023

SELL
N/A
-200 Reduced 2.63%
7,406 $493 Million
Q4 2014

Jun 01, 2023

BUY
N/A
5,815
7,606 $449 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cornerstone Management, Inc. Portfolio

Follow Cornerstone Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Management, Inc. with notifications on news.